The neurosteroid environment in the hippocampus exerts bi-directional effects on seizure susceptibility in mice

Brain Research

Volumn 1243, Issue , 2008, Pages 113-123

  Gililland Kaufman, Katherine R ^a,b   Tanchuck, Michelle A ^a,b   Ford, Matthew M ^a,b   Crabbe, John C ^a,b   Beadles Bohling, Amy S ^a,b   Snelling, Christopher ^a,b   Mark, Gregory P ^a,b   Finn, Deborah A ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

5 reductase; Allopregnanolone; Ethanol; Finasteride; GABAA receptors; Pentylenetetrazol; Withdrawal

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL; FINASTERIDE; NEUROSTEROID; PENTETRAZOLE; STEROID 5ALPHA REDUCTASE;

ALCOHOL BLOOD LEVEL; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONUS; CONTROLLED STUDY; CONVULSION; DRUG EFFICACY; GABAERGIC SYSTEM; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; MALE; MOUSE; MYOCLONUS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SEIZURE SUSCEPTIBILITY;

ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; ANIMALS; ANTICONVULSANTS; CONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPILEPSY; FINASTERIDE; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; MICE; MICE, TRANSGENIC; NEURONS; PENTYLENETETRAZOLE; PREGNANOLONE; SUBSTANCE WITHDRAWAL SYNDROME; TESTOSTERONE 5-ALPHA-REDUCTASE;

ANIMALIA; MUS;

EID: 55649114396     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.09.042     Document Type: Article

References (45)

1. Beckley E.H., Fretwell A.M., Tanchuck M.A., Gililland K.R., Crabbe J.C., and Finn D.A. Decreased anticonvulsant efficacy of allopregnanolone during ethanol withdrawal in female Withdrawal Seizure-Prone vs. Withdrawal Seizure-Resistant mice. Neuropharmacology 54 (2008) 365-374
2. A receptor-mediated inhibitory neurotransmission in the rat hippocampus: evidence for endogenous neurosteroids?. J. Neurosci. 23 (2003) 10013-10020
3. A receptor. Nat. Rev. Neurosci. 6 (2005) 565-575
4. A receptor subunit expression. Neuron 19 (1997) 1103-1114
5. A receptors. Mol. Pharmacol. 63 (2003) 53-64
6. Cagetti E., Pinna G., Guidotti A., Baicy K., and Olsen R.W. Chronic intermittent ethanol (CIE) administration in rats decreases levels of neurosteroids in hippocampus, accompanied by altered behavioral responses to neurosteroids and memory function. Neuropharmacology 46 (2004) 570-579
7. Crabbe J.C., Kosobud A., Young E.R., Tam B.R., and McSwigan J.D. Bidirectional selection for susceptibility to ethanol withdrawal seizures in Mus musculus. Behav. Genet. 15 (1985) 521-536
8. Crabbe J.C., Merrill C.D., and Belknap J.K. Effects of convulsants on handling-induced convulsions in mice selected for ethanol withdrawal severity. Brain Res. 550 (1991) 1-6
9. Crabbe J.C., Young E.R., and Kosobud A. Genetic correlations with ethanol withdrawal severity. Pharmacol. Biochem. Behav. 18 Suppl 1 (1983) 541-547
10. Dave J.R., Tabakoff B., and Hoffman P.L. Ethanol withdrawal seizures produce increased c-fos mRNA in mouse brain. Mol. Pharmacol. 37 (1990) 367-371
11. A receptors to neuroactive steroids in rats during ethanol withdrawal. J. Pharmacol. Exp. Ther. 278 (1996) 510-517
12. Finn D.A., and Crabbe J.C. Chronic ethanol differentially alters susceptibility to chemically induced convulsions in Withdrawal Seizure-Prone and -Resistant mice. J. Pharmacol. Exp. Ther. 288 (1999) 782-790
13. Finn D.A., Douglass A.D., Beadles-Bohling A.S., Tanchuck M.A., Long S.L., and Crabbe J.C. Selected line difference in sensitivity to a GABAergic neurosteroid during ethanol withdrawal. Genes Brain Behav. 5 (2006) 53-63
14. Finn D.A., Ford M.M., Wiren K.M., Roselli C.E., and Crabbe J.C. The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches. Pharmacol. Ther. 101 (2004) 91-112
15. Finn D.A., Gallaher E.J., and Crabbe J.C. Differential change in neuroactive steroid sensitivity during ethanol withdrawal. J. Pharmacol. Exp. Ther. 292 (2000) 394-405
16. A receptor complex. J. Pharmacol. Exp. Ther. 265 (1993) 1374-1379
17. Finn D.A., Long S.L., Tanchuck M.A., and Crabbe J.C. Interaction of chronic ethanol exposure and finasteride: sex and strain differences. Pharmacol. Biochem. Behav. 78 (2004) 435-443
18. Finn D.A., Roberts A.J., and Crabbe J.C. Neuroactive steroid sensitivity in Withdrawal Seizure-Prone and -Resistant mice. Alcohol. Clin. Exp. Res. 19 (1995) 410-415
19. A receptor gene expression by allopregnanolone and ethanol. Eur. J. Pharmacol. 500 (2004) 413-425
20. Frye C.A., and Rhodes M.E. Infusions of 5α-pregnan-3α-ol-20-one (3α,5α-THP) to the ventral tegmental area, but not the substantia nigra, enhance exploratory, anti-anxiety, social and sexual behaviours and concomitantly increase 3α,5α-THP concentrations in the hippocampus, diencephalon and cortex of ovariectomised oestrogen-primed rats. J. Neuroendocrinol. 18 (2006) 960-975
21. Frye C.A., and Vongher J.M. Ventral tegmental area infusions of inhibitors of the biosynthesis and metabolism of 3α,5α-THP attenuate lordosis of hormone-primed and behavioural oestrous rats and hamsters. J. Neuroendocrinol. 13 (2001) 1076-1086
22. Gale K. Progression and generalization of seizure discharge: anatomical and neurochemical substrates. Epilepsia 29 Suppl 2 (1988) S15-S34
23. Gasior M., Carter R.B., and Witkin J.M. Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Trends Pharmacol. Sci. 20 (1999) 107-112
24. Gee K.W., Bolger M.B., Brinton R.E., Coirini H., and McEwen B.S. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J. Pharmacol. Exp. Ther. 246 (1988) 803-812
25. Gorin R.E., Crabbe J.C., Tanchuck M.A., Long S.L., and Finn D.A. Effects of finasteride on chronic and acute ethanol withdrawal severity in the WSP and WSR selected lines. Alcohol. Clin. Exp. Res. 29 (2005) 939-948
26. A receptors in rat CA1 and dentate gyrus neurones. Neuropharmacology 45 (2003) 873-883
27. Herzog A.G., and Frye C.A. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann. Neurol. 53 (2003) 390-391
28. Hirani K., Khisti R.T., and Chopde C.T. Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3α-hydroxy-5α-pregnan-20-one. Neuropharmacology 43 (2002) 1339-1350
29. A receptors in supraoptic nucleus around parturition. J. Neurosci. 23 (2003) 788-797
30. A receptors: genomic and nongenomic mechanisms. Pharmacol. Ther. 101 (2004) 211-226
31. A receptors on CA1 hippocampal neurons is consistent with subunit changes in a model of alcohol withdrawal and dependence. J. Pharmacol. Exp. Ther. 310 (2004) 1234-1245
32. A receptors. J. Neurosci. 26 (2006) 1749-1758
33. Mark G.P., and Finn D.A. The relationship between hippocampal acetylcholine release and cholinergic convulsant sensitivity in Withdrawal Seizure-Prone and Withdrawal Seizure-Resistant selected mouse lines. Alcohol. Clin. Exp. Res. 26 (2002) 1141-1152
34. Metten P., and Crabbe J.C. Alcohol withdrawal severity in inbred mouse (Mus musculus) strains. Behav. Neurosci. 119 (2005) 911-925
35. Morgan P.F., Nadi N.S., Karanian J., and Linnoila M. Mapping rat brain structures activated during ethanol withdrawal: role of glutamate and NMDA receptors. Eur. J. Pharmacol. 225 (1992) 217-223
36. Parada M.A., Puig D.P., and Hoebel B.G. A remote insertion technique for intracerebral microinjections in freely moving animals. J. Neurosci. Methods 50 (1993) 237-241
37. Paxinos G., and Franklin K. The Mouse Brain in Stereotaxic Coordinates. 2nd ed (2001), Academic Press, San Diego, CA
38. Purdy R.H., Morrow A.L., Blinn J.R., and Paul S.M. Synthesis, metabolism, and pharmacological activity of 3-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. J. Med. Chem. 33 (1990) 1572-1581
39. Putzke J., Spanagel R., Tolle T.R., and Zieglgansberger W. The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal. Eur. J. Pharmacol. 317 (1996) 39-48
40. A receptors in the hippocampus may mediate some antiseizure effects of progestins. Epilepsy Behav. 6 (2005) 320-327
41. Rhodes M.E., and Frye C.A. Attenuating 5α-pregnane-3α-ol-20-one formation in the hippocampus of female rats increases pentylenetetrazole-induced seizures. Epilepsy Behav. 6 (2005) 140-146
42. Romeo E., Brancati A., De Lorenzo A., Fucci P., Furnari C., Pompili E., Sasso G.F., Spalletta G., Troisi A., and Pasini A. Marked decrease of plasma neuroactive steroids during alcohol withdrawal. Clin. Neuropharmacol. 19 (1996) 366-369
43. Romeo E., Pompili E., di Michele F., Pace M., Rupprecht R., Bernardi G., and Pasinib A. Effects of fluoxetine, indomethacine and placebo on 3α, 5α tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal. World J. Biol. Psychiatry 1 (2000) 101-104
44. Ströhle A., Romeo E., Hermann B., Pasini A., Spalletta G., di Michele F., Holsboer F., and Rupprecht R. Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol. Psychiatry. 45 (1999) 274-277
45. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., and Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. 95 (1998) 3239-3244